MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma

被引:21
|
作者
Cameron M Smith [1 ]
David I Watson [1 ]
Michael Z Michael [2 ]
Damian J Hussey [1 ]
机构
[1] Department of Surgery, Flinders University, Room 3D211, Flinders Medical Centre, Bedford Park, South Australia 5042, Australia
[2] Department of Gastroenterology & Hepatology, Flinders University, Bedford Park, South Australia 5042, Australia
关键词
Barrett’s esophagus; MicroRNA; Esophageal adenocarcinoma; Transdifferentiation; Tumour suppressor;
D O I
暂无
中图分类号
R735.1 [食管肿瘤]; R571 [食管疾病];
学科分类号
1002 ; 100201 ; 100214 ;
摘要
Barrett’s esophagus is a premalignant condition caused by gastroesophageal reflux. Once developed, it can progress through varying grades of dysplasia to esoph-ageal adenocarcinoma. Whilst it is well accepted that Barrett’s esophagus is caused by gastroesophageal reflux, the molecular mechanisms of its pathogenesis and progression to cancer remain unclear. MicroRNAs (miRNAs) are short segments of RNA that have been shown to control the expression of many human genes. They have been implicated in most cellular processes, and the role of miRNAs in disease development is be-coming increasingly evident. Understanding altered miRNA expression is likely to help unravel the molecular mechanisms that underpin the development of Barrett’s esophagus and its progression to cancer.
引用
收藏
页码:531 / 537
页数:7
相关论文
共 50 条
  • [21] Familial Barrett’s Esophagus and Esophageal Adenocarcinoma
    Joel Gabre
    Amitabh Chak
    Anil Rustgi
    Current Treatment Options in Gastroenterology, 2020, 18 (4) : 616 - 622
  • [22] Biomarkers of esophageal adenocarcinoma and Barrett's esophagus
    McManus, DT
    Olaru, A
    Meltzer, SJ
    CANCER RESEARCH, 2004, 64 (05) : 1561 - 1569
  • [23] Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers
    Grady, William M.
    Yu, Ming
    Markowitz, Sanford D.
    Chak, Amitabh
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (12) : 2486 - 2494
  • [24] Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma
    Runge, Thomas M.
    Abrams, Julian A.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2015, 44 (02) : 203 - +
  • [25] Endoscopy for Barrett's esophagus and esophageal adenocarcinoma
    Shaheen, N
    AMERICAN FAMILY PHYSICIAN, 2004, 69 (09) : 2060 - 2061
  • [26] Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma
    Bresalier, Robert S.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (08) : 2155 - 2162
  • [27] Reflux, Barrett's esophagus and esophageal adenocarcinoma
    Shahar, Eyal
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (12) : 1499 - 1500
  • [28] Esophageal Adenocarcinoma in a First Degree Relative Increases the Risk for Progression to Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
    Tofani, Christina
    Gandhi, Kunjal
    Spataro, Joseph
    Yoo, Joseph
    Murphy, Megan
    Mohan, Neena
    Daitch, Zachary
    Shah, Apeksha
    Janowski, Raymond
    Dabbish, Noreen
    Keith, Scott
    Kastenberg, David
    Coben, Robert M.
    Cohen, Sidney
    Infantolino, Anthony
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S170 - S170
  • [29] Development of Mayo Clinic esophageal adenocarcinoma and Barrett's esophagus registry
    Reddy, RP
    Romero, Y
    Mary, FB
    Teresa, ZG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S36 - S36
  • [30] Barrett's esophagus: progression to adenocarcinoma and markers
    Fang, Dianchun
    Das, Kiron M.
    Cao, Weibiao
    Malhotra, Usha
    Triadafilopoulos, George
    Najarian, Robert M.
    Hardie, Laura J.
    Lightdale, Charles J.
    Beales, Ian L. P.
    Felix, Valter Nilton
    Schneider, Paul M.
    Bellizzi, Andrew M.
    BARRETT'S ESOPHAGUS: THE 10TH OESO WORLD CONGRESS PROCEEDINGS, 2011, 1232 : 210 - 229